Haznadar, M., Diehl, C. M., Parker, A. L., Krausz, K. W., Bowman, E. D., Rabibhadana, S., . . . Harris, C. C. (2019). Urinary Metabolites Diagnostic and Prognostic of Intrahepatic Cholangiocarcinoma. Cancer Epidemiol Biomarkers Prev, 28(10), 1704-1711. doi:10.1158/1055-9965.EPI-19-0453

01 Oct 2019
0

Haznadar, M., Diehl, C. M., Parker, A. L., Krausz, K. W., Bowman, E. D., Rabibhadana, S., . . . Harris, C. C. (2019). Urinary Metabolites Diagnostic and Prognostic of Intrahepatic Cholangiocarcinoma. Cancer Epidemiol Biomarkers Prev, 28(10), 1704-1711. doi:10.1158/1055-9965.EPI-19-0453

Tags

Share this

Related Posts

Evaluation of anti-tumour properties of two depsidones – Unguinol and Aspergillusidone D – in triple-negative MDA-MB-231 breast tumour cells. Zwartsen, A., Chottanapund, S., Kittakoop, P., Navasumrit, P., Ruchirawat, M., Van Duursen, M. B. M. and Van den Berg, M. (2019). Toxicology Reports, 6, 1216-1222.
Molecular dynamics, MM/PBSA and in vitro validation of a novel quinazoline-based EGFR tyrosine kinase inhibitor identified using structure-based in silico screening. Ornnork N, Kiriwan D, Lirdprapamongkol K, Choowongkomon K, Svasti J, Eurtivong C*. J Mol Graph Model. 2020 Sep;99:107639.

Recent Posts